$KRNT Balance Sheet | Understand Stock

$KRNT

$18.20 +$0.33 (1.85%) Close

$KRNT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016
ASSETS
Current Assets
Cash and cash equivalents
Short-term bank deposits
Marketable securities
Trade receivables, net of allowances of $738 and $286, respectively
Trade receivables, net of allowances of $9,746 and $9,243, respectively
Inventories, net
Prepaid expenses and other current assets
Total current Assets

Available for sale marketable securities
Non-current Assets
Marketable securities
Property, plant and equipment, net
Deferred tax assets, net
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Other non-current assets
Deposits and other long-term assets
Severance pay fund
Deferred taxes
Total non-current Assets

Total Assets

LIABILITIES
Current Liabilities
Trade payables
Employee and payroll accruals
Deferred revenues and advances from customers
Deferred revenues and customers’ advances
Operating lease liabilities
Accrued expenses and other current liabilities
Total current Liabilities

Accrued severance pay
Payment obligation related to acquisition
Non-current liabilities
Accrued severance pay
Operating lease liabilities
Other non-current liabilities
Total non-current Liabilities
Total Liabilities
SHAREHOLDERS’ EQUITY
Ordinary shares of NIS 0.01 par value - Authorized: 200,000,000 shares at December 31, 2017 and 2018, respectively; Issued and Outstanding: 34,124,223 shares and 35,065,200 shares at December 31, 2017 and 2018, respectively
Additional paid in capital
Ordinary shares of NIS 0.01 par value - Authorized: 200,000,000 shares at December 31, 2025 and 2024; Issued: 51,922,979 and 51,036,338 shares at December 31, 2025 and 2024, respectively; Outstanding: 45,063,793 and 46,051,461 shares at December 31, 2025 and 2024, respectively.
Additional paid-in capital
Treasury shares at cost, 6,859,186 and 4,984,877 ordinary shares at December 31, 2025 and 2024, respectively.
Accumulated other comprehensive income (loss)
Accumulated deficit
Total Shareholders’ Equity

Total Liabilities and Shareholders’ Equity

Comments